Spear Advisors LLC Takes Position in Astera Labs, Inc. $ALAB

Spear Advisors LLC bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) in the fourth quarter, Holdings Channel.com reports. The fund bought 94,895 shares of the company’s stock, valued at approximately $15,787,000. Astera Labs accounts for 11.1% of Spear Advisors LLC’s portfolio, making the stock its largest position.

Other large investors have also recently made changes to their positions in the company. Assetmark Inc. grew its stake in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Reflection Asset Management purchased a new position in Astera Labs during the 4th quarter worth $25,000. Smartleaf Asset Management LLC increased its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. Hilltop National Bank increased its holdings in Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares during the period. Finally, Aventura Private Wealth LLC purchased a new position in Astera Labs during the 4th quarter worth $33,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 230,639 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $198.22, for a total value of $45,717,262.58. Following the sale, the chief operating officer owned 664,361 shares of the company’s stock, valued at $131,689,637.42. The trade was a 25.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the transaction, the chief executive officer owned 3,929,183 shares of the company’s stock, valued at approximately $786,465,269.28. The trade was a 3.44% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,497,338 shares of company stock valued at $236,827,957 over the last quarter. 12.50% of the stock is owned by company insiders.

Astera Labs Stock Performance

ALAB stock opened at $204.42 on Wednesday. The firm has a market cap of $35.04 billion, a PE ratio of 138.12, a PEG ratio of 3.42 and a beta of 3.35. The firm’s 50 day moving average price is $148.57 and its 200-day moving average price is $155.00. Astera Labs, Inc. has a one year low of $81.14 and a one year high of $262.90.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts predict that Astera Labs, Inc. will post 1.48 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have commented on ALAB. Roth Mkm restated a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Weiss Ratings upgraded Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. UBS Group assumed coverage on Astera Labs in a research report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 target price on the stock. Needham & Company LLC lifted their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Stifel Nicolaus boosted their target price on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Fifteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $229.65.

Read Our Latest Stock Report on ALAB

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.